Unaffected ex vivo clotting cascade by experimental hemostatic nanoparticles when introduced in the presence of recombinant tissue plasminogen activator

CONTEXT: Hemostatic nanoparticles (hNPs) have shown efficacy in decreasing intracerebral hemorrhage (ICH) in animal models and are suggested to be of use to counter tissue plasminogen activator (tPA)-induced acute ICH. AIMS: The objective of this study was to test the ability of an hNP preparation t...

Descripción completa

Detalles Bibliográficos
Autores principales: Beyer, Margaret, France, John, Nagaraja, Tavarekere N., Lavik, Erin B., Knight, Robert A., Lewandowski, Christopher A., Miller, Joseph B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167850/
https://www.ncbi.nlm.nih.gov/pubmed/37181845
http://dx.doi.org/10.4103/bc.bc_45_22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167850/
https://www.ncbi.nlm.nih.gov/pubmed/37181845
http://dx.doi.org/10.4103/bc.bc_45_22

Ejemplares similares